Ms. Collins will also serve as interim CEO. Dr. Khandros will remain on Nutcracker Therapeutics’ board of directors. Dr. Khandros co-founded Nutcracker Therapeutics in 2018, alongside Chief ...

Over the last three months, we've seen a bit of insider buying at CRISPR Therapeutics. Independent Director John Greene bought US$314k worth of shares in that time. But CEO & Chairman Samarth ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...

Amazon's CEO Andy Jassy has announced a shift in the company's promotion strategy, focusing on smaller, efficient teams rather than larger fiefdoms. Highlighting the impact of smaller teams in ...

Felix Baker will succeed Pierre Legault as chairman of the Bicycle Therapeutics (BCYC) board of directors as Legault and Richard Kender, will ...

Strengthened key leadership with cell therapy and autoimmune expertise across organization Robust balance sheet with cash, ...

Hyundai Motor Company CEO Jose Munoz appeared Wednesday on "The Claman Countdown" where he talked about Hyundai Motor Group’s newly-announced massive investment in the U.S. His appearance on the ...

Jong-Hee Han, 63 years old, was appointed co-CEO of Samsung Electronics in December 2021. The company’s other CEO, Jun Young-hyun, oversaw the unit making semiconductors and other tech components.

Venture Global, whose $58 billion market debut fell short of high expectations in January, began generating proceeds in 2022 with its Calcasieu Pass facility. Sawan during Shell's capital markets ...

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is ...